Articles related to BUSINESS & POLICY

The Supreme Court’s deliberations on the Chevron deference and FDA’s drug approval authority underscore a critical juncture for healthcare delivery and regulatory practices, potentially reshaping physician autonomy and patient care standards.

In the evolving landscape of mental health care, AI’s role is becoming increasingly pivotal, offering innovative solutions that enhance patient access, personalize treatment, and address the unique needs of diverse populations.

As physicians, understanding the new biomarker legislation is crucial—it not only shapes insurance coverage but also influences clinical decision-making and patient access to precision medicine, potentially leading to more cost-effective and targeted care.

In a healthcare landscape increasingly dominated by hospital-owned practices, understanding the implications of this shift is crucial for healthcare professionals. The trend raises significant questions about cost, care quality, and the overall structure of healthcare delivery.

The IMLC represents a pivotal shift in telehealth, offering a streamlined licensure process for physicians across multiple states, although its reach is limited by non-participatory states. Understand the compact’s implications on your practice and the broader telehealth landscape.

In oncology, the balance between rapid innovation and patient safety is critical. The recent withdrawal of an accelerated approval cancer drug highlights the need for more stringent evidence and robust trial design to truly benefit patients.